Tag: Retinal Disease

Biocon Sees 3.10% Jump After Securing U.S. Deal for Yesafili Biosimilar—Is This a Game Changer?

Biocon, a global leader in biopharmaceuticals, is making waves in the ophthalmology field with the launch of Yesafili,…